Literature DB >> 19955521

Ablation of tumor progression locus 2 promotes a type 2 Th cell response in Ovalbumin-immunized mice.

Wendy T Watford1, Chun-Chi Wang, Christos Tsatsanis, Lisa A Mielke, Aristides G Eliopoulos, Constantine Daskalakis, Nicolas Charles, Sandra Odom, Juan Rivera, John O'Shea, Philip N Tsichlis.   

Abstract

The protein kinase encoded by the Tpl2 proto-oncogene regulates ERK activation and cytokine gene expression in macrophages in response to LPS and TNF-alpha. In this study we show that OVA-immunized Tpl2(-/-) mice express high levels of IgE and develop more severe bronchoalveolar eosinophilic inflammation than Tpl2(+/+) controls, when challenged with OVA intranasally. Bronchoalveolar exudates and supernatants of OVA-stimulated splenocytes from immunized Tpl2(-/-) mice express elevated levels of IL-4 and IL-5, suggesting that Tpl2 ablation promotes the Th2 polarization of the T cell response. Anti-CD3 stimulation of CD4(+) T cells of wild-type and Tpl2 knockout mice revealed that Tpl2 ablation gives rise to a cell autonomous T cell defect that is primarily responsible for the Th2 polarization of the T cell response to Ag. This observation was further supported by experiments addressing the expression of Th1 and Th2 cytokines in OVA-stimulated mixed cultures of CD4(+) T cells from Tpl2(+/+)/OT2 or Tpl2(-/-)/OT2 mice and dendritic cells from Tpl2(+/+) or Tpl2(-/-) mice. Further studies revealed that Th1 cells express significantly higher levels of Tpl2 than Th2 cells. As a result, Tpl2(-/-) Th1 cells exhibit a stronger defect in ERK activation by anti-CD3 than Th2 cells and express low levels of T-bet. Given that the development of Th1 and Th2 cells depends on positive feedback signals from the T cells, themselves, the functional defect of the Tpl2(-/-) Th1 cells provides a mechanistic explanation for the T cell autonomous Th2 polarization in Tpl2(-/-) mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19955521      PMCID: PMC3044327          DOI: 10.4049/jimmunol.0803730

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

Review 1.  Omalizumab for asthma.

Authors:  Robert C Strunk; Gordon R Bloomberg
Journal:  N Engl J Med       Date:  2006-06-22       Impact factor: 91.245

Review 2.  Development in motion: helper T cells at work.

Authors:  Steven L Reiner
Journal:  Cell       Date:  2007-04-06       Impact factor: 41.582

3.  CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction.

Authors:  Giorgia Gri; Silvia Piconese; Barbara Frossi; Vanessa Manfroi; Sonia Merluzzi; Claudio Tripodo; Antonella Viola; Sandra Odom; Juan Rivera; Mario P Colombo; Carlo E Pucillo
Journal:  Immunity       Date:  2008-11-14       Impact factor: 31.745

4.  Tpl2 and ERK transduce antiproliferative T cell receptor signals and inhibit transformation of chronically stimulated T cells.

Authors:  Christos Tsatsanis; Katerina Vaporidi; Vassiliki Zacharioudaki; Ariadne Androulidaki; Yuri Sykulev; Andrew N Margioris; Philip N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

5.  Novel vaccination for allergy through gene silencing of CD40 using small interfering RNA.

Authors:  Motohiko Suzuki; Xiufen Zheng; Xusheng Zhang; Mu Li; Costin Vladau; Thomas E Ichim; Hongtao Sun; Lisa R Min; Bertha Garcia; Wei-Ping Min
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

6.  Proteinase-activated receptor-1-triggered activation of tumor progression locus-2 promotes actin cytoskeleton reorganization and cell migration.

Authors:  Maria Hatziapostolou; Christos Polytarchou; Dimitrios Panutsopulos; Lidija Covic; Philip N Tsichlis
Journal:  Cancer Res       Date:  2008-03-15       Impact factor: 12.701

7.  Lyn kinase controls basophil GATA-3 transcription factor expression and induction of Th2 cell differentiation.

Authors:  Nicolas Charles; Wendy T Watford; Haydeé L Ramos; Lars Hellman; Hans C Oettgen; Gregorio Gomez; John J Ryan; John J O'Shea; Juan Rivera
Journal:  Immunity       Date:  2009-04-09       Impact factor: 31.745

8.  The role of sphingosine kinase in a murine model of allergic asthma.

Authors:  Wen-Qi Lai; Hong Heng Goh; Zhang Bao; W S Fred Wong; Alirio J Melendez; Bernard P Leung
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

9.  TPL-2 negatively regulates interferon-beta production in macrophages and myeloid dendritic cells.

Authors:  Frank Kaiser; Dorthe Cook; Stamatia Papoutsopoulou; Ricardo Rajsbaum; Xuemei Wu; Huei-Ting Yang; Susan Grant; Paola Ricciardi-Castagnoli; Philip N Tsichlis; Steven C Ley; Anne O'Garra
Journal:  J Exp Med       Date:  2009-08-10       Impact factor: 14.307

10.  Tpl2 kinase regulates T cell interferon-gamma production and host resistance to Toxoplasma gondii.

Authors:  Wendy T Watford; Bruce D Hissong; Lydia R Durant; Hidehiro Yamane; Linda M Muul; Yuka Kanno; Cristina M Tato; Haydeé L Ramos; Alan E Berger; Lisa Mielke; Marko Pesu; Benjamin Solomon; David M Frucht; William E Paul; Alan Sher; Dragana Jankovic; Philip N Tsichlis; John J O'Shea
Journal:  J Exp Med       Date:  2008-11-10       Impact factor: 14.307

View more
  23 in total

1.  Tpl2 inhibitors thwart endothelial cell function in angiogenesis and peritoneal dissemination.

Authors:  Wen-Jane Lee; Keng-Hsin Lan; Chiang-Ting Chou; Yu-Chiao Yi; Wei-Chih Chen; Hung-Chuan Pan; Yen-Chun Peng; Keh-Bin Wang; Yi-Ching Chen; Te-Hsin Chao; Hsing-Ru Tien; Wayne Huey Herng Sheu; Meei-Ling Sheu
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

2.  Tpl2 ablation promotes intestinal inflammation and tumorigenesis in Apcmin mice by inhibiting IL-10 secretion and regulatory T-cell generation.

Authors:  Oksana B Serebrennikova; Christos Tsatsanis; Changchuin Mao; Elias Gounaris; Wenying Ren; Linda D Siracusa; Aristides G Eliopoulos; Khashayarsha Khazaie; Philip N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

3.  TPL2 kinase is a suppressor of lung carcinogenesis.

Authors:  Katerina Gkirtzimanaki; Kalliopi K Gkouskou; Urszula Oleksiewicz; Georgios Nikolaidis; Dimitra Vyrla; Michalis Liontos; Vassiliki Pelekanou; Dimitris C Kanellis; Kostantinos Evangelou; Efstathios N Stathopoulos; John K Field; Philip N Tsichlis; Vassilis Gorgoulis; Triantafillos Liloglou; Aristides G Eliopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-26       Impact factor: 11.205

4.  Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.

Authors:  Xin Li; Nicole V Acuff; Angela R Peeks; Rebecca Kirkland; Kara D Wyatt; Tamas Nagy; Wendy T Watford
Journal:  J Biol Chem       Date:  2016-06-03       Impact factor: 5.157

5.  Apolipoprotein E Signals via TLR4 to Induce CXCL5 Secretion by Asthmatic Airway Epithelial Cells.

Authors:  Or Kalchiem-Dekel; Xianglan Yao; Amisha V Barochia; Maryann Kaler; Debbie M Figueroa; William B Karkowsky; Elizabeth M Gordon; Meixia Gao; Maria M Fergusson; Xuan Qu; Poching Liu; Yuesheng Li; Fayaz Seifuddin; Mehdi Pirooznia; Stewart J Levine
Journal:  Am J Respir Cell Mol Biol       Date:  2020-08       Impact factor: 6.914

6.  Sterile inflammation in acetaminophen-induced liver injury is mediated by Cot/tpl2.

Authors:  Carlos Sanz-Garcia; Gemma Ferrer-Mayorga; Águeda González-Rodríguez; Angela M Valverde; Antonio Martín-Duce; Juan P Velasco-Martín; Javier Regadera; Margarita Fernández; Susana Alemany
Journal:  J Biol Chem       Date:  2013-04-09       Impact factor: 5.157

Review 7.  Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase.

Authors:  Thorsten Gantke; Srividya Sriskantharajah; Steven C Ley
Journal:  Cell Res       Date:  2010-12-07       Impact factor: 25.617

8.  Regulation of experimental autoimmune encephalomyelitis by TPL-2 kinase.

Authors:  Srividya Sriskantharajah; Eva Gückel; Niki Tsakiri; Katrin Kierdorf; Christine Brender; Abduelhakem Ben-Addi; Marc Veldhoen; Philip N Tsichlis; Brigitta Stockinger; Anne O'Garra; Marco Prinz; George Kollias; Steven C Ley
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

9.  TEC and MAPK Kinase Signalling Pathways in T helper (TH) cell Development, TH2 Differentiation and Allergic Asthma.

Authors:  Yashaswini Kannan; Mark S Wilson
Journal:  J Clin Cell Immunol       Date:  2012

10.  Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance.

Authors:  James W Perfield; Yunkyoung Lee; Gerald I Shulman; Varman T Samuel; Michael J Jurczak; Eugene Chang; Chen Xie; Phillip N Tsichlis; Martin S Obin; Andrew S Greenberg
Journal:  Diabetes       Date:  2011-02-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.